Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5064-5069

  Sesti, Giorgio ^a   Perego, Lucia ^b   Cardellini, Marina ^c   Andreozzi, Francesco ^a   Ricasoli, Cristina ^a   Vedani, Paola ^b   Guzzi, Valeria ^b   Marchi, Monica ^b   Paganelli, Michele ^b   Ferla, Gianfranco ^b   Pontiroli, Antonio E ^d   Hribal, Marta Letizia ^a,c   Folli, Franco ^b,e  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Università Magna Græcia di Catanzaro ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GLYCINE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; RESTRICTION ENDONUCLEASE; UNCOUPLING PROTEIN 2;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTION; FEMALE; FOLLOW UP; GASTRIC BANDING; GENOTYPE; HETEROZYGOTE; HOMEOSTASIS; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBSERVATION; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; DIET, REDUCING; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HETEROZYGOTE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; ION CHANNELS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY, MORBID; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; PPAR GAMMA; WEIGHT LOSS;

EID: 24344437704     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0404     Document Type: Article

References (34)

1. Kopelman PG 2000 Obesity as a medical problem. Nature 404:635-643
2. Pontiroli EA, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F 2002 Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555-3561
3. Masud S, Ye S 2003 Effect of the peroxisome proliferator activated receptor-γ gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773-780
4. Ek J, Urhammer SA, Sørensen TIA, Andersen T, Auwerx J, Pedersen O 1999 Homozygosity of the Pro12Ala variant of the peroxisome proliferation- activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-895
5. Nicklas BJ, van Rossum EFC, Berman DM, Ryan AS, Dennis KE, Shuldiner AR 2001 Genetic variation in the peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50:2172-2176
6. Lindi VI, Uusitupa MIJ, Lindstrom J, Louheranta A, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group 2002 Association of the Pro12Ala polymorphism in the PPAR-γ2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish diabetes prevention study. Diabetes 51:2581-2586
7. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O 1993 Amino acid polymorphism of insulin receptor substrate-1 in non-insulin- dependent diabetes mellitus. Lancet 342:828-832
8. Jellema A, Zeegers MPA, Feskens EJM, Dagnelle PC, Mensink RP 2003 The Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 46:990-995
9. Zeggini E, Parkinson J, Halford S, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, Sampson MJ, Feskens EJM, Hattersley AT, McCarthy MI 2004 Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetic samples enriched for family history and early age of onset. Diabetes 53:3319-3322
10. Florez JC, Sjogren M, Burtt N, Orho-Melander M, Schayer S, Sun M, Almgren P, Lindblad U, Tuomi T, Gaudet D, Hudson TJ, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L 2004 Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes 53:3313-3318
11. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099-2111
12. 972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013
13. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K 1995 Insulin resistance: interaction between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397-402
14. Baroni MG, Arca M. Sentinelli F, Buzzetti R, Capici F, Lovari S, Vitale M, Romeo S, Di Mario U 2001 The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia 44:367-372
15. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH 1997 Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272
16. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W 2001 A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178-183
17. Fried SK, Bunkin DA, Greenberg AS 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850
18. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE 2001 Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9:414-417
19. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79
20. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P 1998 The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376
21. Berthier M-T, Paradis A-M, Tchernof A, Bergeron J, Prud'homme D, Després J-P, Vohl M-C 2003 The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48:14-19
22. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapaa P, Vauhkonen I, Laakso M 2003 The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52:558-561
23. Anonymous 1995 Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. WHO Tech Rep Ser 854:1-452
24. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1998 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21:S5-S19
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM 1994 The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res 28:425-445
27. 972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368-3371
28. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, Lauro D, De Nicolais P, Sbraccia P, Del Prato S, Gambardella S, Federici M, Marchetti P, Lauro R 2003 A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52:1280-1283
29. Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern GJ 2004 Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326-351
30. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP 1997 Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62
31. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S 1998 Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 95:3251-3256
32. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR 2000 Responses of the sympathetic nervous system and the hypothalamic- pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43:872-880
33. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP 1996 Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271:E601-E605
34. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ 1995 Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 80:3052-3058